Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Gulf Keystone Petroleum
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Kurdistan Pipeline Restart Will Secure Future Oil Market Access
Key Takeaways Kurdish pipeline export restart and improved government payments could enhance revenue and cash flow stability. Cost discipline and strategic shareholder distributions may positively impact earnings and EPS growth.
View narrative
UK£2.01
FV
14.5% undervalued
intrinsic discount
20.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
13
users have followed this narrative
1 day ago
author updated this narrative
Speedy Hire
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Upgrades And AFC Energy Partnership Will Drive Efficiency
Key Takeaways Investment in eco-friendly solutions and hydrogen partnerships positions Speedy Hire for sustainable growth amid increased demand for reduced emissions. Enhancements in logistics, service centers, and infrastructure contracts are set to boost operational efficiency, revenue, and strengthen market position.
View narrative
UK£0.47
FV
35.8% undervalued
intrinsic discount
5.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
1 day ago
author updated this narrative
Sanlorenzo
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Nautor Swan And Simpson Marine Acquisitions Will Fuel APAC Presence
Key Takeaways Strategic acquisitions and product innovation aim to drive significant future revenue growth, enhancing Sanlorenzo's market position. International expansion and strong pre-orders contribute to financial stability and long-term revenue growth despite geopolitical challenges.
View narrative
€47.53
FV
36.7% undervalued
intrinsic discount
2.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
1 day ago
author updated this narrative
Ardelyx
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Global Healthcare And Aging Trends Will Unleash Market Opportunity
Key Takeaways Expanding markets, better market access, and prescription growth are accelerating adoption of core therapies, supporting sustained revenue and margin improvement. International partnerships and new indications diversify revenue streams, mitigate risks, and enhance long-term earnings stability.
View narrative
US$11.18
FV
46.6% undervalued
intrinsic discount
22.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
56
users have followed this narrative
1 day ago
author updated this narrative
NFI Group
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Record Backlog And Government Funding Will Expand Bus Market
Key Takeaways Market tailwinds from electrification mandates and government funding strongly support recurring order growth, expanding NFI's addressable market and long-term earnings stability. Operational improvements, supply chain normalization, and expansion of aftermarket services are expected to drive higher manufacturing efficiency and more resilient margins.
View narrative
CA$23.77
FV
21.0% undervalued
intrinsic discount
21.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
1 day ago
author updated this narrative
Integral Diagnostics
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Upgraded MRI Licensing And Merger Synergies Will Fuel Future Success
Key Takeaways Synergies from the Capitol Health merger and regulation changes are expected to boost operating margins and revenue for Integral Diagnostics. Strategic investments and leveraging of teleradiology capabilities aim to optimize costs and support future revenue growth amidst market expansions.
View narrative
AU$3.12
FV
14.7% undervalued
intrinsic discount
21.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
1 day ago
author updated this narrative
Perpetual
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Capital Influx And Cost Savings Will Secure Future Flexibility
Key Takeaways The sale of the Wealth Management business will provide capital to reduce debt, enhancing financial flexibility and potentially improving net margins and earnings. Strategic focus on cost savings, new asset management strategies, and international growth is expected to diversify revenues and positively impact earnings.
View narrative
AU$20.76
FV
4.5% overvalued
intrinsic discount
1.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
1 day ago
author updated this narrative
Aroa Biosurgery
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
CMS Reforms And International Expansion Will Drive US Healthcare Adoption
Key Takeaways New reimbursement policies and clinical milestones are set to boost product adoption, drive higher revenue, and improve margins through greater operating leverage. Strong market demand, underpenetrated existing accounts, and international expansion present significant long-term growth opportunities and diversified revenue streams.
View narrative
AU$0.83
FV
24.4% undervalued
intrinsic discount
16.96%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
33
users have followed this narrative
1 day ago
author updated this narrative
Emergent BioSolutions
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Global MCM Demand And Political Risks Will Shape Outlook
Key Takeaways Growing government demand and global expansion drive revenue predictability, diversification, and increased stability across medical countermeasure and health preparedness markets. Improved operating efficiency and financial strength enable greater investment in innovation, supporting sustained growth and enhanced earnings potential.
View narrative
US$13.50
FV
34.5% undervalued
intrinsic discount
-4.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies